Dr Aslam Sohaib is a Consultant Radiologist at the Royal Marsden Hospital, London, UK. He gained his medical degree from Guy’s Hospital Medical School, London and then obtained his general medical training in Cambridge. He undertook specialist training in Diagnostic Radiology followed a body MRI fellowship at St Bartholomew’s and the Royal London Hospitals. He was appointed as a Consultant Radiologist at the Royal Marsden Hospital in 2000. The Royal Marsden Hospital is the national cancer centre for the UK. Dr Sohaib provides diagnostic imaging services for all cancer at the Marsden but is the lead radiologist for genito-urinary cancer imaging.

In addition to providing diagnostic imaging services to the Radiology Department, he is the training program director for specialist registrar undergoing sub-speciality training in oncological imaging.  Dr Sohaib also teaches and lectures on many international courses eg UK radiology congress, ESUR and ICIS. As a fellow of the International Cancer Imaging Society (ICIS) he has developed interactive courses on gynaecological imaging.

Dr Sohaib has written widely on a variety of topics related to cancer imaging. He has published over 100 peer reviewed journal papers and contributed to over 25 book chapters. He has been associate editor for American Journal of Roentgenology and Imaging and reviews manuscripts regularly for the major radiology journals. He is actively involved in clinical research with his major research interest being related to the use of CT and MR imaging in patients with genito-urinary malignancies.

Most recent publications:

Have over 114 peer reviewed publication and have contributed to over 25 book chapter:

1. Thian, Y., A. Gutzeit, D.M. Koh, et al., Revised Choi Imaging Criteria Correlate with Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib. Radiology, 2014: p. 132702.

2. Tree, A., C. Jones, A. Sohaib, et al., Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method? Radiat Oncol, 2013. 8(1): p. 228.

3. Tang, Y.Z., S. Liyanage, P. Narayanan, et al., The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns. Eur Radiol, 2013. 23(1): p. 48-56.

4. Kirkham, A.P., P. Haslam, J.Y. Keanie, et al., Prostate MRI: Who, when, and how? Report from a UK consensus meeting. Clin Radiol, 2013. 68(10): p. 1016-23.

5. Horwich, A., D.P. Dearnaley, A. Sohaib, et al., Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma. Ann Oncol, 2013. 24(8): p. 2104-7.

6.Dickinson, L., H.U. Ahmed, C. Allen, et al., Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging, 2013. 37(1): p. 48-58.

7. Brockbank, E.C., V. Harry, D. Kolomainen, et al., Laparoscopic staging for apparent early stage ovarian or fallopian tube cancer. First case series from a UK cancer centre and systematic literature review. Eur J Surg Oncol, 2013. 39(8): p. 912-7.

8. Beyer, J., P. Albers, R. Altena, et al., Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol, 2013. 24(4): p. 878-88.

9. Arumainayagam, N., H.U. Ahmed, C.M. Moore, et al., Multiparametric MR Imaging for Detection of Clinically Significant Prostate Cancer: A Validation Cohort Study with Transperineal Template Prostate Mapping as the Reference Standard. Radiology, 2013. 268(3): p. 761-9.

10. Andreou, A., C. Whitten, D. MacVicar, et al., Imaging appearance of sarcomas of the prostate. Cancer Imaging, 2013. 13: p. 228-37.